LIVZON PHARMA Receives Vietnamese Regulatory Approval for IMP Share Tender Offer

Stock News

03/06

LIVZON PHARMA (01513) has announced that its overseas wholly-owned subsidiary, LIANSGP HOLDING PTE. LTD. (LIANSGP), has formally received approval documents from the Vietnamese State Securities Commission for its proposed public tender offer to acquire shares in IMP. The company's board of directors had previously approved the proposal to acquire equity in the Vietnamese company IMP and to launch a public tender offer for its shares during meetings held on May 22, 2025, and December 30, 2025. Following these board resolutions, LIANSGP submitted the relevant application for the tender offer to the Vietnamese regulatory authority. The company stated it will actively advance the matters related to this transaction.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1173968783"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1173968783\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1173968783?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 18:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173968783","market":"hk","top_or_hot":-1,"title":"LIVZON PHARMA Receives Vietnamese Regulatory Approval for IMP Share Tender Offer","media":"Stock News","content":"<p>LIVZON PHARMA (01513) has announced that its overseas wholly-owned subsidiary, LIANSGP HOLDING PTE. LTD. (LIANSGP), has formally received approval documents from the Vietnamese State Securities Commission for its proposed public tender offer to acquire shares in IMP. The company's board of directors had previously approved the proposal to acquire equity in the Vietnamese company IMP and to launch a public tender offer for its shares during meetings held on May 22, 2025, and December 30, 2025. Following these board resolutions, LIANSGP submitted the relevant application for the tender offer to the Vietnamese regulatory authority. The company stated it will actively advance the matters related to this transaction.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LIVZON PHARMA Receives Vietnamese Regulatory Approval for IMP Share Tender Offer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLIVZON PHARMA Receives Vietnamese Regulatory Approval for IMP Share Tender Offer\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-03-06 18:58</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>LIVZON PHARMA (01513) has announced that its overseas wholly-owned subsidiary, LIANSGP HOLDING PTE. LTD. (LIANSGP), has formally received approval documents from the Vietnamese State Securities Commission for its proposed public tender offer to acquire shares in IMP. The company's board of directors had previously approved the proposal to acquire equity in the Vietnamese company IMP and to launch a public tender offer for its shares during meetings held on May 22, 2025, and December 30, 2025. Following these board resolutions, LIANSGP submitted the relevant application for the tender offer to the Vietnamese regulatory authority. The company stated it will actively advance the matters related to this transaction.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_FVN","symbol_name":"富時越南30指數","start_time":0,"source_url":"","article_id":"1173968783","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173968783","pubTimestamp":1772794696,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"LIVZON PHARMA (01513) has announced that its overseas wholly-owned subsidiary, LIANSGP HOLDING PTE. LTD. (LIANSGP), has formally received approval documents from the Vietnamese State Securities...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"161027":"证券","BK1191":"制药","01513":"丽珠医药"},"translate_title":"丽珠医药IMP股份要约收购获得越南监管机构批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1,"01513":1,"FVNmain":1},"content_text":"LIVZON PHARMA (01513) has announced that its overseas wholly-owned subsidiary, LIANSGP HOLDING PTE. LTD. (LIANSGP), has formally received approval documents from the Vietnamese State Securities Commission for its proposed public tender offer to acquire shares in IMP. The company's board of directors had previously approved the proposal to acquire equity in the Vietnamese company IMP and to launch a public tender offer for its shares during meetings held on May 22, 2025, and December 30, 2025. Following these board resolutions, LIANSGP submitted the relevant application for the tender offer to the Vietnamese regulatory authority. The company stated it will actively advance the matters related to this transaction.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}